Home / Hematology
Hematology
| 2 min read
Ascentage Pharma to initiate Phase 1b study of HQP1351 in tyrosine kinase inhibitors-resistant chronic myeloid leukemia patients in the U.S.
| 3 min read
A look at a recent FDA decision and analyst forecasts in the field of liquid biopsy
| 10+ min read
It’s never just been about killing or removing tumors; it’s about aiming at them accurately
| 3 min read
The pharma giant is gearing up to acquire Array BioPharma for $11.4 billion
| 2 min read
Be The Match BioTherapies and TrakCel partner to standardize cell and gene therapy supply chain solutions
| 2 min read
Reistone announces first patient dosed in two Phase 2 global studies of SHR0302, a JAK1 inhibitor for ulcerative colitis and Crohn’s disease
| 3 min read
Company looks to advance its Reveal ctDNA 20 kits and AMP-based target enrichment system
| 3 min read
Arcus and Strata announce clinical development collaboration for AB122 and predictive biomarkers
| 2 min read
MI Transcriptome companion diagnostic test receives FDA Breakthrough Device Designation
| 10+ min read
Drilling to the core of life itself: Researchers go deep into the world of metabolomics to find new therapeutic possibilities with metabo-oncology
| 3 min read
CStone and Bayer look to evaluate PD-L1 monoclonal antibody CS1001 in combination with regorafenib
